Our Portfolio

Life-Science Intellectual property Platform Fund (LSIP)

Outline IP fund that will cross organizational boundaries to collect intellectual property from universities, research institutes,etc. in four key fields of key life science and increase its value before licensing it to pharmaceutical companies, etc.
Website

http://www.ipsn.co.jp/bundling.html

Industry Health/medicine
Commercialization stage Early stage

Provided Support

  • Crosses organizational boundaries to collect IP from universities, public research institutes, etc.
  • Forms and licenses attractive IP clusters, and facilitates their use in innovative technology or creation of venture companies
Authorized Investment ¥1 billion (maximum)
Announcement Date Aug 06, 2010
Investment Structure

Related Press Releases

Jan 31, 2017
INCJ announces conclusion of support for life science intellectual property fund LSIP
HOME
About Us
Our Business
Newsroom
Our Investments